Iosif Koutagiar
Overview
Explore the profile of Iosif Koutagiar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vlachopoulos C, Solomou E, Terentes Printzios D, Pouli A, Sioni A, Giannouli S, et al.
JACC Adv
. 2024 Jun;
2(2):100277.
PMID: 38938303
Background: Despite advances in the treatment of oncology patients, therapy-related side effects may lead to premature morbidity. Inflammatory activation that has been linked to cardiovascular disease is crucial for the...
2.
Rallidis L, Rizos C, Papathanasiou K, Liamis G, Skoumas I, Garoufi A, et al.
J Cardiovasc Med (Hagerstown)
. 2024 Mar;
25(5):370-378.
PMID: 38526957
Aims: Three physical signs, namely tendon xanthomas, corneal arcus and xanthelasma, have been associated with heterozygous familial hypercholesterolemia (heFH). The prevalence and clinical significance of these signs are not well...
3.
Barkas F, Rizos C, Liamis G, Skoumas I, Garoufi A, Rallidis L, et al.
J Clin Lipidol
. 2024 Feb;
18(3):e394-e402.
PMID: 38331687
Background: Familial hypercholesterolemia (FH) and obesity are well-established risk factors of atherosclerotic cardiovascular disease (ASCVD). Despite high prevalence, their joint association with ASCVD remains largely unknown. Objective: To investigate the...
4.
Antza C, Rizos C, Kotsis V, Liamis G, Skoumas I, Rallidis L, et al.
Biomedicines
. 2024 Jan;
12(1).
PMID: 38275402
Background: Familial hypercholesterolemia (FH) carries a high risk of atherosclerotic cardiovascular disease (ASCVD). As the population ages, the age-related influence on clinical characteristics and outcomes becomes increasingly pertinent. This cross-sectional...
5.
Boutari C, Rizos C, Doumas M, Liamis G, Skoumas I, Rallidis L, et al.
Pharmaceuticals (Basel)
. 2023 Jan;
16(1).
PMID: 36678541
Familial hypercholesterolemia (FH) and type 2 diabetes mellitus (T2DM) are both associated with a high risk of atherosclerotic cardiovascular disease (ASCVD). Little is known about the prevalence of T2DM and...
6.
Benetos G, Galanakos S, Koutagiar I, Skoumas I, Oikonomou G, Drakopoulou M, et al.
J Clin Med
. 2021 Nov;
10(21).
PMID: 34768528
Background: Microwave radiometry (MWR) assesses non-invasive carotid artery temperatures reflecting inflammation. In the present study, we aimed to investigate the impact of hypolipidemic therapy either with simvastatin or with combination...
7.
Papageorgiou C, Zagouri F, Tampakis K, Georgakopoulou R, Manios E, Kafouris P, et al.
Front Cardiovasc Med
. 2021 Mar;
8:638895.
PMID: 33732735
Chemotherapy regimens for breast cancer treatment can promote vascular dysfunction and lead to high cardiovascular risk. To investigate the cardiovascular burden and vascular inflammation in metastatic breast cancer patients receiving...
8.
Anagnostis P, Rizos C, Skoumas I, Rallidis L, Tziomalos K, Skalidis E, et al.
Curr Pharm Des
. 2021 Feb;
27(21):2537-2544.
PMID: 33593250
Aims: Despite the established link between familial hypercholesterolemia (FH) and increased risk of coronary heart disease (CHD), its association with other common atherosclerotic and metabolic diseases has not been extensively...
9.
Toutouzas K, Antonopoulos A, Koutagiar I, Skoumas I, Benetos G, Kafouris P, et al.
J Nucl Cardiol
. 2021 Jan;
29(3):1405-1414.
PMID: 33501546
Background: The role of adipose tissue (AT) in arterial inflammation in familial dyslipidaemias is poorly studied. We investigated the relationship between AT and arterial inflammation in patients with heterozygous familial...
10.
Rizos C, Florentin M, Skoumas I, Tziomalos K, Rallidis L, Kotsis V, et al.
Lipids Health Dis
. 2020 May;
19(1):114.
PMID: 32466791
Background: Familial hypercholesterolemia (FH) is characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels and increased cardiovascular disease (CVD) risk. FH patients often have increased lipoprotein(a) [Lp(a)] levels, which further increase...